Strength
8 mg/mL
Manufacturer
Astellas Pharma US, Inc.NDC
00469502099
Classification
Brand
Dosage Form
GRANULE, FOR SUSPENSION, EXTENDED RELEASE
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
MIRABEGRONApproval Type
New Drug (NDA)
FDA Application
NDA213801On Market Since
3/25/2021
Pharmacological Classes
Adrenergic beta3-Agonists
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors
beta3-Adrenergic Agonist
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
ZONISADE 100 MG/5 ML ORAL SUSP
Brand
52652800101•Azurity Pharmaceuticals Inc.
$2.7530
per ML
NEORAL 25 MG GELATIN CAPSULE
Brand
00078024615•Novartis Pharmaceuticals Corporation
$2.8879
per EA
KALETRA 80 MG-20 MG/ML SOLN
Brand
00074395646•AbbVie Inc.
$3.1186
per ML
KATERZIA 1 MG/ML SUSPENSION
Brand
52652500101•Azurity Pharmaceuticals Inc.
$4.1914
per ML
SANDIMMUNE 25 MG CAPSULE
Brand
00078024015•Novartis Pharmaceuticals Corporation
$4.3773
per EA
ZOLOFT 20 MG/ML ORAL CONC
Brand
00049005001•Roerig
$4.5486
per ML
ZOLOFT 20 MG/ML ORAL CONC
Brand
58151060135•Viatris Specialty LLC
$4.5486
per ML
BRILINTA 90 MG TABLET
Brand
00186077739•AstraZeneca Pharmaceuticals LP
$7.4222
per EA
BRILINTA 90 MG TABLET
Brand
00186077760•AstraZeneca Pharmaceuticals LP
$7.4222
per EA
BRILINTA 60 MG TABLET
Brand
00186077660•AstraZeneca Pharmaceuticals LP
$7.4281
per EA